New Launch4 Sept 2025, 02:17 pm
Navin Fluorine International Ltd. Achieves Commissioning Readiness for Phase 1 of New cGMP-4 Facility at Dewas
AI Summary
Navin Fluorine International Ltd. has announced that Phase 1 of their new cGMP-4 facility at Dewas has achieved commissioning readiness. This phase, which has a capital expenditure of approximately Rs. 160 crores, has begun validation batches for their European partner. The company will separately announce the commencement of commercial production. This update is in line with their earlier intimation dated February 06, 2024, regarding a total capital expenditure of Rs. 288 crores for the new facility.
Key Highlights
- Navin Fluorine International Ltd. has achieved commissioning readiness for Phase 1 of their new cGMP-4 facility at Dewas.
- The capital expenditure for Phase 1 is approximately Rs. 160 crores.
- Validation batches have commenced for their European partner.
- The company will separately announce the commencement of commercial production.
- This update is in line with their earlier intimation dated February 06, 2024, regarding a total capital expenditure of Rs. 288 crores for the new facility.